Abstract:
Background: Worldwide, infectious diseases are an important cause of morbidity
and mortality. The World Health Organization (WHO) estimates that by 2050, these
diseases are anticipated to contribute to 13 million deaths worldwide annually,
mainly due to antimicrobial resistance. A contributing factor to antimicrobial
resistance is the irrational use of antimicrobial agents. To promote the rational use of
medicines, specific indicators are used to give an overall pattern of drug usage. The
WHO (2012) published a set of key indicators that can rapidly and reproducibly
evaluate key antimicrobial usage patterns in a hospital setting. It is important to
optimize antimicrobial use to reduce healthcare costs and alleviate rising
antimicrobial resistance and associated mortality.
Objective: To assess antimicrobial usage in the adult medical wards of Moi
Teaching and Referral Hospital (MTRH) using selected WHO hospital, prescribing,
patient care, and supplemental indicators.
Method: This descriptive study was designed using the WHO (2012) prescribed tool
to assess 14 specific indicators under the subsections: hospital, prescribing, patient
care, and supplemental indicators. Two key informants and their offices provided
information: the director of clinical services and the chief pharmacist; and from
patient files. Out of 1,138 patients who were eligible (over 18 years and on treatment
with an antimicrobial agent), 394 study participants were selected using systematic
sampling over 3 months (February to April 2019). Data were entered into Microsoft
Excel (MS Office 2010) and analyzed as means, medians, and frequencies
(descriptive statistics) as detailed in the WHO tool.
Results: Concerning hospital indicators, there was a lack of standard treatment
guidelines for infectious diseases and an up-to-date hospital-specific formulary list.
Based on the hospital inventory, only 62.6% of listed antimicrobials were available
on day one of the study, while antimicrobials were out of stock for 8.7 days per
month. Of the total drug expenditure, 29.4% was spent purchasing antimicrobial
agents. Though the WHO recommends 100% use of generic names when
prescribing, adherence was only 86.9%. Management of pneumonia complied (98%)
with international guidelines. The number of antimicrobials prescribed per patient
per hospitalization was between 2 and 3. The average cost, length of therapy, and
hospital stay per patient per hospitalization were KShs. 5,727.97/= (USD 52.14); 8.2
days; and 12.2 days respectively. Only 67.3% of antimicrobials prescribed on the
treatment records were actually administered. Seventeen (17) out of 83 samples
taken for culture had microbial growth.
Conclusion: There were no hospital-specific standard treatment guidelines for
infectious diseases, no up-to-date formulary list, and frequent stock-outs of
antimicrobial agents. There was high treatment cost and an unacceptable level of
prescribed antimicrobial doses not administered to patients. Prescribing of
antimicrobials was largely empiric.
Recommendations: A study to determine possible causes and solutions to the
gaps identified.